(Q36181238)

12 August 2017

title

Low molecular weight heparin in acute stroke (English)

1 reference

ORCID Public Data File 2021

12 August 2017

1 reference

1 reference

author name string

Bath PM

series ordinal

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

published in

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

8

1 reference

12 August 2017

page(s)

1323-1330

1 reference

Complications of acute stroke

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

Treating acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

Low molecular weight heparin in prevention of perioperative thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

Low-molecular-weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

Anticoagulant therapy in acute cerebrovascular accidents. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.8.1323

10.1517/13543784.7.8.1323

21 January 2018

Identifiers

DOI

1 reference

release_pftvkuvfmba5dannt4e6tcltwu

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pftvkuvfmba5dannt4e6tcltwu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference